Alkermes plc (ALKS) Offers Prelim. Data from ALKS 7119 Phase 1; Plans Acceleration into Second Clinical Trial

April 28, 2016 7:01 AM

Alkermes plc (Nasdaq: ALKS) announced preliminary findings from a phase 1 clinical trial of ALKS 7119, an oral, novel small ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found